In all seriousness, the availability of Monepantel in other forms (such as Sheep drenching - ~$400 per litre, 25mg / ml solution) does concern me. How much of a premium will we be able to charge? I'd say if we started trying to charge >$10k per treatment, patients would look to source their Monepantel elsewhere. And of that $10k, how much would PAA likely see? (assuming a licensing deal).
I realise Sheep drench may not sound very enticing, but I'm just using it as an example (& whilst I haven't tried it, it probably doesn't taste THAT bad!). As another example, if PAA's Monepantel could sell for $10k per treatment, what's to stop someone contract manufacturing a competing product - call it "Oral worming tablets, recommended for goats but safe for humans too". And selling them for the equivalent of $1k per treatment...
Would appreciate others thoughts. How much of a competitive moat would we really have?
- Forums
- ASX - By Stock
- PAA
- Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow), page-61
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.76M |
Open | High | Low | Value | Volume |
20.5¢ | 20.5¢ | 20.0¢ | $86.39K | 425.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 245685 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 204582 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 245685 | 0.200 |
6 | 229570 | 0.195 |
4 | 155324 | 0.190 |
11 | 505988 | 0.185 |
10 | 549536 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 204582 | 4 |
0.210 | 302539 | 9 |
0.215 | 276995 | 8 |
0.220 | 734043 | 11 |
0.225 | 232889 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online